ABCB1 and renal cell carcinoma: The intrinsic drug resistance in RCC, always impairing the efficiency of chemotherapy, has been ascribed to the overexpression of multiple-drug resistance protein (P-glycoprotein) and multiple-drug resistance-associated protein 1 (MRP1) in 80% to 100% of RCC tumors [3].